Navigation Links
Leading Healthcare Organizations Share Successes Realized with MEDai's Predictive Analytics
Date:3/16/2009

- MEDai Clients Present at the 6th Annual New Innovations & Applications

in Predictive Modeling Conference -

ORLANDO, Fla., March 16 /PRNewswire/ -- MEDai, Inc., headquartered in Orlando, FL, and a leading provider of advanced solutions for healthcare that utilize award-winning predictive analytics, announced today that several of its clients will be presenting the benefits and successes they have realized from utilizing MEDai's suite of predictive analytic solutions. The presentations, taking place during World Research Group's 6th Annual New Innovations & Applications in Predictive Modeling Conference in Las Vegas, NV, March 25-26, 2009, will provide insight on how payors can maximize and improve resource allocation, improve the impact of care management efforts, and more effectively engage members and physicians in the healthcare delivery process.

MEDai's suite of predictive analytic solutions is designed to meet the needs of multiple constituents. This is evidenced by the wide spectrum of clients presenting on MEDai's behalf. Novant Health will share how MEDai's predictive solutions can be applied in the outpatient care environment to allow physicians to access health plan data in real-time for support in evaluating and managing high-risk patients within their practices and in acute care settings. Another client, Sentara Healthcare, will share how they have successfully identified their employer clients' pain points and provided specific reporting and analysis to improve the overall health plan-employer communication process. Finally, during a 3-hour workshop, several other clients will team together to discuss demonstrable ROI, realized through the use of this technology, and innovative concepts to help employers and health plans gain control over rising health plan benefit costs.

"Limited resources require effective allocation and management, and while there is plenty of disparate data available to help with this, many stakeholders do not have the analytical tools that bring that data together and generate accurate, actionable insights," said Swati Abbott, president of MEDai. "MEDai's focus has always and continues to be, creating clinically-focused solutions that provide key information in a timely manner such that everyone involved in the healthcare delivery process can be positively impacted."

About MEDai

MEDai, Inc. is a subsidiary of Elsevier a world-leading publisher of scientific, technical and medical information products and services. For more than a decade, MEDai has been offering award-winning solutions for the improvement of healthcare delivery. Utilizing cutting-edge technology, payors and care management organizations are able to predict patients at risk, identify cost drivers for their high-risk population, forecast future health plan costs, evaluate patient patterns over time and improve outcomes. For more information on MEDai, visit www.medai.com.

    For More Information Contact:
    Lizzy Feliciano, MBA,
    Manager
    Marketing & Communications
    MEDai, Inc.
    (800) 446-3324


'/>"/>
SOURCE MEDai, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Gamma Pharmaceuticals Accepts PO From Leading St. Louis Missouri Distributor. Order Valued up to $850,000 Retail Market Value
2. Stereotaxis Signs Agreement With Leading Leasing Specialist to Offer Alternative Financing to Hospital Customers
3. Three Leading Proxy Advisory Firms are Unanimous in Recommending LCA-Vision Stockholders Support the Current Board of Directors
4. Leading German Healthcare Group Selects Equipment and Software from Varian Medical Systems for Major Replacement Project
5. The Rev. Joseph C. Martin, Leading Authority on Alcoholism and Addiction Treatment, Dies at 84
6. Leading Domestic Violence Expert Comments on New Developments in the Rihanna/Chris Brown Case
7. Dallas-based MedNetwoRx Leading the Way With Healthcare Reform
8. Follow-Up Tests of Leading Personal Care and Household Cleaning Brands Reveal Improvements in Levels of Carcinogenic 1,4-dioxane
9. Leading Proxy Advisory Firm RiskMetrics Recommends Shareholders Support LCA-Vision Board of Directors and Reject All Proposals by Dissident Joffe Group
10. Naturally Safe Zucol(TM) Brings Europes Leading Cold Remedy to United States
11. NHPCO Comments on Misleading Quote in Associated Press Article and Provides Helpful Information
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... (PRWEB) , ... September 25, 2017 , ... ... further expand its Portable, Continuous, Miniature, and Modular (PCMM) collaboration with Pfizer and ... POD-based Oral Solid Dosage line. The new PODs will provide tablet coating capability ...
(Date:9/25/2017)... ... 25, 2017 , ... Lean Management techniques applied to the ... First-Defect-Stop for laboratory weighing is designed to help laboratory personnel strengthen lab ... consequences on downstream processes. , If a problem is detected, the "First-Defect-Stop" procedure ...
(Date:9/25/2017)... ... , ... The Asset Tracking and Temperature monitoring system works in conjunction with ... bar code of the product and lot ID then scanning the HPP basket and ... automatically generated and exception alerts sent out to designated individuals. , "In recognizing the ...
(Date:9/25/2017)... ... September 25, 2017 , ... Earlypicker is expanding its offerings to ... for the hottest Korean cosmetics and fashion trends sweeping the nation. The decision to ... well-known for the great offerings that allow Koreans everywhere to look their best every ...
(Date:9/25/2017)... ... September 25, 2017 , ... “Grandpa's Visit”: a tender and relatable ... with the others. “Grandpa's Visit” is the creation of published author, Beverly Brumfield, gifted ... much like the character in her book. She shares, “Mr. Rice is struggling to ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... Sept. 9, 2017  Eli Lilly and Company (NYSE: ... secondary endpoint data for lasmiditan, an investigational, oral, first-in-class ... statistically significant improvements compared to placebo in the Phase ... at the 18th Congress of the International Headache Society ... "The data presented today demonstrate lasmiditan,s potential to reduce ...
(Date:9/7/2017)... 2017  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... that it will be participating in the Morgan Stanley ... Grand Hyatt hotel in New York.  Zimmer Biomet will ... Eastern Time. A live webcast of the ... website at http://investor.zimmerbiomet.com .   ...
(Date:9/6/2017)... WILMINGTON, Del. , Sept. 6, 2017 NeuroRx, ... for Acute Suicidal Ideation and Behavior (ASIB), has been granted ... for its sequential therapy of NRX-100 (ketamine HCl) followed by ... patients in a pivotal trial of this sequential therapy targeting ... bipolar depression. 1 ...
Breaking Medicine Technology: